USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: ACERA BIOSCIENCES, INC.
City: WAYZATA
State: MN
Zip+4: 55391
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: (952) 475-4929

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $590,993.00 5

Award List:

GENERATION OF KETOLIDES BY COMBINATORIAL BIOSYNTHESIS

Award Year / Program / Phase: 1999 / SBIR / Phase I
Agency: HHS
Principal Investigator: Yongquan Xue
Award Amount: $100,000.00
Abstract:
Not Available Scientific Research Corporation (SRC) proposes to design and develop a handheld terminal that is easily carried and used by soldiers operating in view of an High Altitude Endurance (MAE) Unmanned Aerial Vehicle (UAV) such as the Global Hawk or DarkStar. Communications through the UAV… More

N/A

Award Year / Program / Phase: 2000 / SBIR / Phase I
Agency: HHS
Principal Investigator: Lishan Zhao
Award Amount: $98,580.00

Improving Glycosyltransferase by RACHITT Gene Shuffling

Award Year / Program / Phase: 2001 / SBIR / Phase I
Agency: HHS
Principal Investigator: Yongquan Xue
Award Amount: $100,000.00
Abstract:
DESCRIPTION (provided by applicant): Glycosyltransferases involved in linking polyketide macrolactones with deoxysugars are key enzymes for combinatorial biosynthesis of novel macrolide anti-infective agents. In this proposal, a new gene shuffling technology, RACHITT, is… More

COMBINATORIAL BIOSYNTHESIS OF NOVEL BIOREDUCTIVE AGENTS

Award Year / Program / Phase: 2002 / SBIR / Phase I
Agency: HHS
Principal Investigator: Yingqing Mao
Award Amount: $148,400.00
Abstract:
DESCRIPTION (provided by applicant): The structural and biosynthetic similaritybetween FR900482 and mitomycin (MC) group of antitumor antibiotics makes it promising to rationally create novel mitomycin/FR900482 hybrids through combinatorial biosynthesis. After successful identification of both MC… More

Heterologous Expression of Marine Natural Products

Award Year / Program / Phase: 2003 / SBIR / Phase I
Agency: HHS
Principal Investigator: Yongquan Xue
Award Amount: $144,013.00
Abstract:
DESCRIPTION (provided by applicant): Marine natural products are diverse in chemical structure and have great biological activities, especially anticancer activities. However, developing these compounds into clinical drugs has been hindered by their limited supply. Acera Biosciences, Inc. has… More